Novo Nordisk (manufacturer of semaglutide drugs Ozempic, Vegovy) and Eli Lilly (manufacturer of tirzepatide drugs Mounjaro, Zepbound) have become some of the most valuable companies in the world, and the global market for GLP-1/GIP analogues is projected to grow to $150 billion by 2030
The developed model has classified 2015 thalassemic patients and 3051 non-thalassemic patients from the dataset
Published December 11, 2024
Among the main non-enzymatic antioxidants are glutathione, uric acid, bilirubin, melatonin, vitamins C and E, carotenoids, polyphenols, and trace elements such as selenium and zinc
Key warning signs include cloudiness or turbidity, which suggests protein aggregation or precipitation
This small size belies its structural fragility